Project Grant 2423679
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$295K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85741, USA
Similar Awards
The National Science Foundation awarded Theracea Pharma LC a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop bioconjugation and preparation of fluorine-18 biomolecules for positron emission tomography (PET) imaging. The grant period runs from August 15, 2021 through July 31, 2023 in Tucson, Arizona. Under this award, Theracea Pharma LC will work to advance science and engineering research and innovation leading to breakthrough...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is funding the research and development of a multi-mode instrument for cancer diagnosis and treatment in companion animals. The $274,999 award to Therafluor Inc., a for-profit manufacturer, aims to develop a low-cost medical instrument that can visualize, target, and effectively eliminate cancerous cells in companion pets using a novel...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Redpoint Oncology, Inc. aims to develop and validate a novel platform for targeted cancer therapies. The project will design and synthesize new payload candidates, test their effectiveness and selectivity against therapy-resistant cancer cells, and establish proof-of-concept for this innovative therapeutic approach. The broader impact includes addressing critical unmet...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Om Therapeutics Inc. in La Jolla, CA aims to enable the discovery of new medicines at an unprecedented rate. The project will seek to demonstrate the ability to screen billions of unique small molecules against the entire human proteome, using pico-scale compartments to dramatically reduce the cost and time required for such screens. The key goals are to: (1)...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Glow Therapeutics Inc. aims to advance a novel light-activatable nanoplatform for the targeted co-delivery of photodynamic therapy (PDT) and chemotherapy to treat peritoneal metastasis. The Phase I project will focus on developing a scalable manufacturing process, determining the optimal drug administration route, and identifying the PDT activation threshold for this...
This $365,887 federal Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an innovative artificial intelligence (AI) technology to select optimal treatment options for individual cancer patients. The goal is to prolong patient life and reduce healthcare costs by avoiding initial treatment failures. The project will establish connections with innovation networks, accelerate market-oriented...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Bired Imaging Inc. aims to develop an innovative breast cancer screening technology that can accurately detect malignant tumors, even in dense breast tissue. The project will utilize infrared imaging to capture the heat signature of the breast surface and leverage a physics-based AI algorithm to back-calculate the size and location of potential tumors. The goal is to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Technology Transfer (STTR) award of $275,000 provides funding to Vivosphere LLC in Auburn, Alabama to develop a novel tissue-engineered platform for more effective cancer drug screening. The project aims to create a 3D hydrogel scaffold that provides a more physiologically relevant microenvironment for cell growth and drug response, enabling higher-throughput and more predictive...